HHHHHHHHHHHHHHIUSOO5324717A United States Patent Is 11 Patent Number: 5,324,717 Berglindh Et Al
Total Page:16
File Type:pdf, Size:1020Kb
HHHHHHHHHHHHHHIUSOO5324717A United States Patent is 11 Patent Number: 5,324,717 Berglindh et al. 45) Date of Patent: Jun. 28, 1994 (54) THERAPEUTICAL COMPOSITION 56) References Cited COMPRISING HYDROLYZED U.S. PATENT DOCUMENTS CARBOXYLALKYL CELLULOSE 4,444,761 4/1984 Spiller ................................. 514/867 76) Inventors: Thomas Berglindh, Ripvägen 5, S-756 4,579,943 4/1986 Kamide et al. ....................... 536/98 53 Uppsala; Anthony de Belder, - FOREIGN PATENT DOCUMENTS Nantunavagen 36 F, S-757 57 Uppsala, both of Sweden 0189886 6/1986 European Pat. Off. OTHER PUBLICATIONS 21) Appl. No.: 941,119 - Danhof, Ivan E., Pharmacotherapy, vol. 2, pp. 18-28 (22) PCT Filed: May 3, 1991 and table 1, (1982). Pigman, W. W., Chemistry of the Carbohydrates, pp. (86 PCT No.: PCT/SE91/00317 530, 532, 545, (1948). Kennedy, John F., Carbohydrate Chemistry, pp. 48-49; S371 Date: Nov. 4, 1992 614, (1988). S 102(e) Date: Nov. 4, 1992 Primary Examiner-Ronald W. Griffin Attorney, Agent, or Firm-Birch, Stewart, Kolasch & (87) PCT Pub. No.: WO91/16906 Birch PCT Pub. Date: Nov. 14, 1991 57 ABSTRACT (30) Foreign Application Priority Data A therapeutical composition comprising hydrolyzed carboxyalkyl cellulose, wherein alkyl is methyl, ethyl or May 4, 1990 SE Sweden............................... 90 O1592 propyl, optionally in salt form, which hydrolyzed car 51) Int. Cl.......................... A61K 31/72; C08L 1/28 boxyalkyl cellulose has a mass average molecular mass 52) U.S. C. ................................... 514/57; 106/1972; from about 200 to about 10,000. A method for providing 514/781; 514/867; 536/85; 536/89; 536/97; a laxative effect comprises the administration of such a 536/98 composition. 58) Field of Search ....................... 536/85, 89, 97,98; 106/1972; 514/57, 867, 781 12 Claims, 5 Drawing Sheets U.S. Patent June 28, 1994 Sheet 1 of 5 5,324,717 Figure 1. Score, 24 hours 0.5 1 15 2 2.5 ml/rat/day U.S. Patent June 28, 1994 sheet 2 of 5 5,324,717 Figure 2. ml/rat/day U.S. Patent June 28, 1994 Sheet 3 of 5 5,324,717 Figure 3. Score, 72 hours O O.S 1 1S 2 25 ml/rat/day U.S. Patent June 28, 1994 Sheet 4 of 5 5,324,717 FIGURE 4. Diarrhea Score CMC-Na iml E CMC- Na 2 ml In CMC- Mg 1 ml S CMC-Mg 2 m |---- H -Z2 DAYS-?lllllllll?” CMC adm.ØZ day 1-3 ZZZZZZZZZZ U.S. Patent June 28, 1994 Sheet 5 of 5 5,324,717 H-CMC 168 mg E H-CMC 335 mg | N-CMC 335 mg S N-CMC 670 mg T - - s N st at: 3 to es Sla o N On-R Ea s N C as R. N T |N T N. N. IN N DAY Mean+SEM, p<0.05, two tails. Adm. 2x7 m/3 days 5,324,717 1. 2 of gases, which may cause abdominal pains and also is a THERAPEUTICAL COMPOSITION COMPRISING social inconvenience. HYDROLYZED CARBOXYLALKYL CELLULOSE There is therefore still a need for an efficient slowact ing osmotic (bulk-forming) laxative with better effi FIELD OF THE INVENTION ciency than lactulose and lacking disadvantageous side The present invention relates to the use of hydro effects. lyzed carboxyalkyl cellulose as a therapeutical, a therapeutical composition comprising hydrolyzed car SUMMARY OF THE INVENTION boxyalkyl cellulose, methods of preparing such a com 10 An object of the present invention is therefore to position, and the use of hydrolyzed carboxyalkyl cellu provide an osmotic laxative which is more efficient than lose for the manufacture of the therapeutical composi conventional osmotic laxatives, such as lactulose. tion. Another object of the invention is to provide an effi BACKGROUND OF THE INVENTION cient osmotic laxative substantially devoid of any detri Laxatives and catharitics are drugs that promote defe 15 mental side-effects. cation. Whereas laxative effect means the elimination of Still another object of the invention is to provide an a soft, formed stool, the term cathartic implies a more osmotic laxative which is cheap and readily available. fluid evacuation of the bowels. The laxatives can It has now surprisingly been found that hydrolysis broadly be classified into four major groups, viz. emol products of carboxyalkyl celluloses, and more particu lient laxatives, bulk-forming laxatives, osmotic laxatives 20 larly hydrolyzed carboxymethyl, carboxyethyl or car and irritants. boxypropyl cellulose, have remarkable osmotic laxative The emollient laxatives, or fecal softeners, are drugs properties which far exceed those of lactulose and un that promote defecation by modest softening of the hydrolyzed native carboxymethyl cellulose (bulk-form faeces. Examples are dioctyl sodium sulfosuccinate and 25 ing) while substantially being devoid of any detrimental some mineral oils. side-effects. Bulk-forming laxatives include various natural and Thus, in one aspect, the present invention provides a semisynthetic polysaccharides and cellulose deriva therapeutical composition comprising hydrolyzed car tives. These substances dissolve or swell in water to boxyalkyl cellulose, wherein alkyl is methyl, ethyl or form an emollient gel or viscous solution that serves to 30 propyl, said hydrolyzed carboxyalkyl cellulose having a maintain the faeces soft and hydrated. The resulting mass average molecular mass (Mw) from about 200 to bulk promotes peristalsis, and transit time is reduced. about 10 000 and optionally being in salt form. The Examples of bulk-forming laxatives are methylcellu hydrolyzed product may thus be a hydrolyzed carboxy lose, sodium carboxymethyl cellulose, and vegetable methyl, carboxyethyl or carboxypropyl cellulose, or fibers like Testa Isphaghula. 35 Osmotic laxatives are small non-absorbable molecules mixtures thereof, but also mixed-carboxyalkyl substi which by osmotic force draw water into the intestines tuted hydrolysis products, such as carboxymethyl/car and can either be fast-acting like Glauber's salt (Na2 boxyethyl oligosaccharides, are intended to be encom SO4) or slow-acting like lactulose. From a mechanistic passed by the invention. The preferred hydrolyzed standpoint lactulose must be classified as an osmotic carboxyalkyl cellulose is hydrolyzed carboxymethyl laxative, but the function will be that of a bulk laxative, cellulose. For convenience, carboxymethyl cellulose is since water, i.e. a mass, is drawn into the intestine. hereinafter frequently referred to as CMC, and the Irritants, finally, induce water secretion and bowel hydrolysis product thereof as H-CMC. mobility by chemical action. Examples are bisacodyl, In another aspect the present invention provides castor oil, phenolphtalein, and anthraquinone glyco 45 methods of preparing the therapeutical composition. sides (Sennosides A and B). In still another aspect the present invention provides Bulk-forming laxatives like methyl cellulose and so a hydrolyzed carboxyalkyl cellulose as defined above dium carboxymethyl cellulose are hydrophilic semisyn for use as a therapeutical, and specifically as a laxative. thetic cellulose derivatives marketed under various In another aspect the present invention provides the trade names. Their laxative effect is, however, not quite SO use of a hydrolyzed carboxyalkyl cellulose as defined satisfactory. This is reflected by the numerous prior art above for the preparation of a laxative composition. disclosing the use of carboxymethyl cellulose as a car rier, thickener and additive for compositions with laxa BRIEF DESCRIPTION OF THE DRAWINGS tive or cathartic action where the pharmacological The above and other objects, features and advantages effect is largely due to the presence of an active agent, 55 e.g. magnesium hydroxide, attapulgite, diphenolisatin; of the present invention will become apparent from the see, for example, EP-A-1 19479, GB-A-1 158 169, JP-B- following description and the appended claims, taken in 63026692, and FR-A-64982647. conjunction with the accompanying drawings, in The above mentioned osmotic laxative lactulose is a which: disaccharide consisting of fructose and galactose. The FIGS. 1-3 are dose-response curves for lactulose and laxative effect of lactulose is thought to be due to the hydrolyzed CMC-Na induced diarrhoea in rats after 24, lower molecular weak acids formed in the degradation 48 and 72 hours, respectively; of the substance giving a bulk effect by osmotically FIG. 4 is a score chart representation of a comparison binding water and thereby exerting a regulating effect of hydrolyzed CMC-Mg and CMC-Na induced diar upon the peristalsis. Lactulose has, however, several 65 rhoea in rats; and disadvantages in that it is needed in very large quanti FIG. 5 is a score chart representation of a comparison ties, is very slow-acting and that the degradation of hydrolyzed CMC-Na and native CMC induced diar thereof comprises the formation of substantial amounts roea in rats. 5,324,717 3 4. duration of the hydrolysis will determine the final mo-' DETAILED DESCRIPTION OF THE lecular weight range. INVENTION The depolymerization reactions may be conducted The hydrolyzed carboxyalkyl cellulose product in by heating a dilute solution, e.g. 1-20% (w/v), prefera the laxative composition according to the present in bly 5-15% (w/v), of the particular carboxyalkyl cellu vention consists of oligosaccharides of carboxymethyl, lose, or carboxyalkyl cellulose mixture, with an acid for carboxyethyl or carboxypropyl cellulose, optionally a suitable period of time. The acid may be a mineral acid mixedly substituted, or mixtures thereof, and has a mass or an organic acid. Examples of mineral acids are hy average molecular mass (MW) from about 200 to about drochloric acid and phosphoric acid, while trifluoro 10 000, preferably from about 300 to about 2000. The 10 acetic acid and formic acid may be mentioned as exam hydrolyzed product contains molecules of DP in the ples of organic acids. The preferred acid is dilute hydro range from about 1 to about 50. Preferably, however, chloric acid with a molarity between about 0.05 and the mean DP (DP) of the hydrolyzed carboxyalkyl about 1.5M, preferably from about 0.1 to about 0.8M.